Jade Biosciences, Inc.
JBIO
$15.26
$0.040.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Net Income | -26.42% | -26.84% | 21.66% | 15.81% | |
| Total Depreciation and Amortization | 0.00% | -25.00% | 500.00% | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -21.27% | 114.72% | -59.58% | -43.06% | |
| Change in Net Operating Assets | 188.63% | -889.48% | -158.36% | 15.43% | |
| Cash from Operations | 28.43% | -52.09% | -9.75% | -7.47% | |
| Capital Expenditure | -- | 94.74% | 58.09% | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 91.37% | 33.97% | -- | -- | |
| Cash from Investing | 91.37% | 33.99% | -109,244.12% | -- | |
| Total Debt Issued | -- | -1,209.13% | -107.10% | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -99.99% | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 96.61% | -270.28% | 206.25% | -1,856.00% | |
| Cash from Financing | -100.47% | -- | -100.00% | 27,429.71% | |
| Foreign Exchange rate Adjustments | 58.82% | -325.00% | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -187.01% | 122.44% | -199.90% | 978.93% | |